nimbin has been researched along with rhodamine 123 in 1 studies
| Studies (nimbin) | Trials (nimbin) | Recent Studies (post-2010) (nimbin) | Studies (rhodamine 123) | Trials (rhodamine 123) | Recent Studies (post-2010) (rhodamine 123) |
|---|---|---|---|---|---|
| 25 | 0 | 13 | 1,760 | 10 | 424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Hazani, TM; Aljarba, NH; Arockiaraj, J; Arokiyaraj, S; Guru, A; Sudhakaran, G; Velayutham, M | 1 |
1 other study(ies) available for nimbin and rhodamine 123
| Article | Year |
|---|---|
Nimbin (N1) and analog N3 from the neem seeds suppress the migration of osteosarcoma MG-63 cells and arrest the cells in a quiescent state mediated via activation of the caspase-modulated apoptotic pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azadirachta; Caspases; Cell Line, Tumor; Cell Proliferation; Osteosarcoma; Rats; Rhodamine 123; Seeds; Zebrafish | 2023 |